Mammoth Biosciences

Mammoth Biosciences specializes in leveraging its proprietary ultracompact CRISPR systems for long-term curative therapies and decentralized precision diagnostics, enabling in vivo gene editing in difficult-to-reach tissues and offering nuclease applications, base editing, gene writing, and epigenetic editing.